Clinical Trials Browser

Phase 2 × Carcinoma, Squamous Cell × olaparib × Clear all

NCT05366166 2026-01-28

Pembrolizumab Plus Olaparib in LA-HNSCC

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell